EdgarLookup

Howard Hughes Holdings Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Howard Hughes Holdings Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
8.4%
Profit Margin
Net income ÷ revenue
1.2%
Return on Assets
Net income ÷ assets
1.8x
Debt-to-Equity
Total liabilities ÷ equity
+49.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.47B Feb 19, 2026
FY2025 Dec 31, 2024 $983.59M Feb 19, 2026
FY2025 Sep 30, 2024 $327.15M Feb 19, 2026
FY2025 Jun 30, 2024 $283.47M Feb 19, 2026
FY2025 Mar 31, 2024 $156.48M Feb 19, 2026
FY2024 Dec 31, 2023 $312.96M Feb 26, 2025
FY2024 Sep 30, 2023 $228.47M Feb 26, 2025
FY2024 Jun 30, 2023 $185.78M Feb 26, 2025
FY2024 Mar 31, 2023 $181.54M Feb 26, 2025
FY2024 Dec 31, 2022 $1.49B Feb 26, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $123.90M Feb 19, 2026
FY2025 Dec 31, 2024 $156.32M Feb 19, 2026
FY2025 Sep 30, 2024 $72.77M Feb 19, 2026
FY2025 Jun 30, 2024 $21.09M Feb 19, 2026
FY2025 Mar 31, 2024 ($52.48M) Feb 19, 2026
FY2024 Dec 31, 2023 $34.30M Feb 26, 2025
FY2024 Sep 30, 2023 ($544.18M) Feb 26, 2025
FY2024 Jun 30, 2023 ($19.14M) Feb 26, 2025
FY2024 Mar 31, 2023 ($22.75M) Feb 26, 2025
FY2024 Dec 31, 2022 $184.53M Feb 26, 2025

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $331.52M Feb 19, 2026
FY2025 Dec 31, 2024 $260.51M Feb 19, 2026
FY2025 Sep 30, 2024 $198.34M Feb 19, 2026
FY2025 Jun 30, 2024 $88.46M Feb 19, 2026
FY2025 Mar 31, 2024 $12.61M Feb 19, 2026
FY2024 Dec 31, 2023 $105.12M Feb 26, 2025
FY2024 Sep 30, 2023 $59.38M Feb 26, 2025
FY2024 Jun 30, 2023 $13.94M Feb 26, 2025
FY2024 Mar 31, 2023 $37.79M Feb 26, 2025
FY2024 Dec 31, 2022 $424.24M Feb 26, 2025

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $462.37M Feb 19, 2026
FY2025 Dec 31, 2024 $396.59M Feb 19, 2026
FY2025 Dec 31, 2023 ($258.48M) Feb 19, 2026
FY2024 Dec 31, 2022 $325.25M Feb 26, 2025
FY2023 Dec 31, 2021 ($283.96M) Feb 27, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.64B Feb 19, 2026
FY2025 Dec 31, 2024 $9.21B Feb 19, 2026
FY2024 Dec 31, 2023 $9.58B Feb 26, 2025
FY2023 Dec 31, 2022 $9.60B Feb 27, 2024

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.80B Feb 19, 2026
FY2025 Dec 31, 2024 $6.37B Feb 19, 2026
FY2024 Dec 31, 2023 $6.52B Feb 26, 2025
FY2023 Dec 31, 2022 $6.00B Feb 27, 2024

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.78B Feb 19, 2026
FY2025 Dec 31, 2024 $2.78B Feb 19, 2026
FY2024 Dec 31, 2023 $2.99B Feb 26, 2025
FY2023 Dec 31, 2022 $3.54B Feb 27, 2024

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.34M Feb 19, 2026
FY2025 Dec 31, 2024 $0 Feb 19, 2026

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($62.10M) Feb 19, 2026
FY2025 Dec 31, 2024 ($185.99M) Feb 19, 2026
FY2024 Dec 31, 2023 ($383.70M) Feb 26, 2025
FY2023 Dec 31, 2022 $168.08M Feb 27, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.47B Feb 19, 2026
FY2025 Dec 31, 2024 $596.08M Feb 19, 2026
FY2025 Dec 31, 2023 $629.71M Feb 19, 2026
FY2024 Dec 31, 2022 $610.21M Feb 26, 2025
FY2023 Dec 31, 2021 $843.21M Feb 27, 2024

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.11B Feb 19, 2026
FY2024 Dec 31, 2024 $5.13B Feb 26, 2025
FY2023 Dec 31, 2023 $5.30B Feb 27, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 19, 2026
FY2025 Dec 31, 2024 3 Feb 19, 2026
FY2025 Sep 30, 2024 1 Feb 19, 2026
FY2025 Jun 30, 2024 0 Feb 19, 2026
FY2025 Mar 31, 2024 (1) Feb 19, 2026
FY2024 Dec 31, 2023 0 Feb 26, 2025
FY2024 Sep 30, 2023 (10) Feb 26, 2025
FY2024 Jun 30, 2023 0 Feb 26, 2025
FY2024 Mar 31, 2023 0 Feb 26, 2025
FY2024 Dec 31, 2022 3 Feb 26, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 19, 2026
FY2025 Dec 31, 2024 3 Feb 19, 2026
FY2025 Sep 30, 2024 1 Feb 19, 2026
FY2025 Jun 30, 2024 0 Feb 19, 2026
FY2025 Mar 31, 2024 (1) Feb 19, 2026
FY2024 Dec 31, 2023 0 Feb 26, 2025
FY2024 Sep 30, 2023 (10) Feb 26, 2025
FY2024 Jun 30, 2023 0 Feb 26, 2025
FY2024 Mar 31, 2023 0 Feb 26, 2025
FY2024 Dec 31, 2022 3 Feb 26, 2025

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 59.37M Feb 19, 2026
FY2025 Dec 31, 2024 50.12M Feb 19, 2026
FY2024 Dec 31, 2023 50.04M Feb 26, 2025
FY2023 Dec 31, 2022 49.80M Feb 27, 2024